Top

Published in:

Open Access 01-12-2018 | Commentary

Low Dose Medicine: theoretical background and scientific evidence

Author: S. Bernasconi

Published in: Italian Journal of Pediatrics | Issue 1/2018

Excerpt

The paper recently published by Carello R. et al. Long-term treatment with Low Dose Medicine in chronic childhood eczema. A double-blind two-stage randomized clinical trial (IJP 2017 43:78) highlights a new possible therapeutic approach for the treatment of chronic childhood eczema. It is based on the oral administration of low doses activated interleukin 12 and Interferon-γ in order to restore the immunologic balance, altered in the disease. This short commentary will briefly describe the theoretical background of Low Dose Medicine (LDM), with particular focus on the aspects linked with the efficacy and the safety of the LDM treatment. …

Ader R, Cohen N, Felten DL. Brain, behavior, and immunity. Brain Behav Immun. 1987;1(1):1–6.CrossRefPubMed

Ader R, Felten D, Cohen N. Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol. 1990;30:561–602.CrossRefPubMed

Ader R, Cohen N. Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol. 1993;44:53–85.CrossRefPubMed

Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet. 1995;345(8942):99–103.CrossRefPubMed

Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137–62.CrossRefPubMed

Ngoc PL, Gold DR, Tzianabos AO, Weiss ST, Celedón JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol. 2005;5(2):161–6.CrossRefPubMed

Lourenço EV, La Cava A. Cytokines in systemic lupus erythematosus. Curr Mol Med. 2009;9(3):242–54.CrossRefPubMedPubMedCentral

Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33(3):378–455.CrossRefPubMedPubMedCentral

Biancotto A, Wank A, Perl S, Cook W, Olnes MJ, et al. Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects. PLoS One. 2013;8(12):e76091.CrossRefPubMedPubMedCentral

10.

Reeves R, Leonard WJ, Nissen MS. Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene. Mol Cell Biol. 2000;20(13):4666–79.CrossRefPubMedPubMedCentral

11.

Ishihara K, Hirano T. Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta. 2002;1592(3):281–96.CrossRefPubMed

12.

Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol. 2010;125(2 suppl 2):S53–72.CrossRefPubMed

13.

Bacchus W, Aubel D, Fussenegger M. Biomedically relevant circuit-design strategies in mammalian synthetic biology. Mol Syst Biol. 2013;9:691.CrossRefPubMedPubMedCentral

14.

Weigent DA, Blalock JE. Associations between the neuroendocrine and immune systems. J Leukoc Biol. 1995;58(2):137–50.CrossRefPubMed

15.

Haddad JJ. On the mechanisms and putative pathways involving neuroimmune interactions. Biochem Biophys Res Commun. 2008;370(4):531–5.CrossRefPubMed

16.

De la Fuente M. Editorial: crosstalk between the nervous and the immune systems in health and sickness. Curr Pharm Des. 2014;20(29):4605–7.CrossRefPubMed

17.

Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S20–31.CrossRefPubMedPubMedCentral

18.

Bollyky PL, Bogdani M, Bollyky JB, Hull RL, Wight TN. The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep. 2012;12(5):471–80.CrossRefPubMedPubMedCentral

19.

Borroni EM, Mantovani A, Locati M, Bonecchi R. Chemokine receptors intracellular trafficking. Pharmacol Ther. 2010;127(1):1–8.CrossRefPubMed

20.

Farrell MS, Roth BL. Pharmacosynthetics: reimagining the pharmacogenetic approach. Brain Res. 2013;1511:6–20.CrossRefPubMed

21.

Burnett AF, Biju PG, Lui H, Hauer-Jensen M. Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model. Radiat Res. 2013;180(6):595–602.CrossRefPubMedPubMedCentral

22.

Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, et al. Delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology. 2014;146(1):210–21.CrossRefPubMed

23.

Forster K, Goethel A, Chan CW, Zanello G, Streutker C, et al. An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice. Gastroenterology. 2012;143(5):1298–307.CrossRefPubMed

24.

Yun Y, Cho YW, Park K. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev. 2013;65(6):822–32.CrossRefPubMed

25.

Epstein OI. Release-activity: a long way from phenomenon to new drugs. Bull Exp Biol Med. 2012;154(1):54–8.CrossRefPubMed

26.

Gariboldi S, Palazzo M, Zanobbio L, Dusio GF, Mauro V, Solimene U, Cardani D, et al. Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther. 2009;22(6):497–510.CrossRefPubMed

27.

D’Amico L, Ruffini E, Ferracini R, Roato I. Low dose of IL-12 stimulates T cell response in cul- tures of PBMCs derived from non small cell lung cancer patients. J Cancer Ther. 2012;3:337–42.CrossRef

28.

Cardani D, Dusio GF, Luchini P, Sciarabba M, Solimene U, Rumio C. Oral Administration of Interleukin-10 and anti-IL1 antibody ameliorates experimental intestinal inflammation. Gastroenterol Res. 2013;6(4):124–33.

29.

Radice E, Miranda V, Bellone G. Low-doses of sequential-kinetic-activated interferon-gamma enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study intern. Immunopharmacology. 2014;19(1):66–73.CrossRef

30.

Roberti ML, Ricottini L, Capponi A, Sclauzero E, Vicenti P, Fiorentini E, Savoia C, et al. Im- munomodulating treatment with low dose inter- leukin-4, Interleukin-10 and Interleukin-11 in psoriasis vulgaris. J Biol Regul Homeost Agents. 2014;28(1):133–9.PubMed

31.

Luchetti P. Increasing of visual function in patients with retinal atrophy treated with drugs of Low Dose Medicine. Monocentric retrospective observational study. Minerva Oftalmol. 2014;56(3–4):53–61.

32.

Barygina V, Becatti M, Lotti T, Moretti S, Taddei N, Fiorillo C. Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin. J Dermatol Sci. 2015;79(2):163–70.CrossRefPubMed

33.

Lotti T, Hercogova J, Wollina U, Chokoeva AA, Zarrab Z, Gianfaldoni S, Roccia MG, et al. Viti- ligo: successful combination treatment based on oral low dose cytokines and different topical tre- atments. J Biol Regul Homeost Agents. 2015;29(1 Suppl):53–8.PubMed

34.

Radice E, Bellone G, Miranda V. Enhancement of the Immunostimulatory functions of ex vi- vo-generated Dendritic cells from early-stage colon cancer patients by consecutive exposure to low doses of sequential-kinetic-activated IL-4 and IL-12. A Preliminary Study. Transl Oncol. 2015;8(4):327–38.CrossRefPubMedPubMedCentral

35.

Lotti T. Successful combination treatment for psoriasis with phototherapy and low-dose cytoki- nes : a spontaneous, retrospective observational clinical study. Hautarzt. 2015;66(11):849–54.CrossRefPubMed

36.

Barygina V, Becatti M, Lotti T, Taddei N, Fiorillo C. Low dose cytokines reduce oxidative stress in primary lesional fibroblasts obtained from psoriatic patients. J Dermatol Sci. 2016;83(3):242–4.CrossRefPubMed

37.

Fiorito F, Cantiello A, Granato GE, Navas L, Diffidenti C, De Martino L, Maharajan V, Fiorito F, et al. Clinical improvement in feline herpesvirus 1 infected cats by oral low dose of interleukin-12 plus interferon-gamma. Comparative Immuno- logy. Microbiol Infect Dis. 2016;48:41–7.

38.

Genazzani AD, Prati A, Bonacini R, Despini G. Terapia integrativa e farmacologica dell'amenorrea ipotalamica da stress. Boll Ginecol Endocrinol. 2016;10:24–32.

39.

Martin-Martin LS, Giovannangeli F, Bizzi E, Massafra U, Ballanti E, Cassol M, Migliore A. An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis. Drug Des Devel Ther. 2017;11:985–94.CrossRefPubMedPubMedCentral

40.

Castiglioni S, Miranda V, Cazzaniga A, Campanella M, Nichelatti M, Andena M, Maier JAM. Femtograms of Interferon-γ Suffice to Modulate the Behavior of Jurkat Cells: A New Light in Immunomodulation. Int J Mol Sci. 2017;18(12):2714-15.

41.

Mancini F, Milardi D, Carfagna P, Grande G, Miranda V, De Cicco NA, Ricciardi D, Pontecorvi A, et al. Low-dose SKA progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines. Int Immunopharmacol. 2018;55:223–30.CrossRef

42.

Humrich JY, von Spee-Mayer C, Siegert E, Alexander T, Hiepe F, Radbruch A, Burmester GR, et al. Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE. Ann Rheum Dis. 2015;74(4):791–2.CrossRefPubMed

43.

Jyonouchi S, Gwafila B, Gwalani LA, Ahmad M, Moertel C, Holbert C, Kim JY, et al. Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome. Clin Immunol. 2017;179:47–53.CrossRefPubMed

Title: Low Dose Medicine: theoretical background and scientific evidence
Author: S. Bernasconi
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Italian Journal of Pediatrics / Issue 1/2018
Electronic ISSN: 1824-7288
DOI: https://doi.org/10.1186/s13052-018-0460-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Low Dose Medicine: theoretical background and scientific evidence

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2018

What family doctors know about congenital CMV: a regional survey in Iran

The impact of nasal aspiration with an automatic device on upper and lower respiratory symptoms in wheezing children: a pilot case-control study

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

Indications and complications of inpatient parenteral nutrition prescribed to children in a large tertiary referral hospital

Fibrin glue pleurodesis for pneumothorax in extremely preterm infants: a case report and literature review

Guidelines on pediatric day surgery of the Italian Societies of Pediatric Surgery (SICP) and Pediatric Anesthesiology (SARNePI)